Immunovant Ownership 2024 | Who Owns Immunovant Now?


OverviewForecastFinancialsChart

Institutional Ownership

48.21%

Insider Ownership

55.98%

Retail Ownership

-4.20%

Institutional Holders

232.00

Immunovant Institutional Shareholders


Institutional Shareholders by % of Total Shares

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
FMR LLC5.30%0.02%7,655,945-219,877-2.79%247,363,595Mar 31, 2024
VANGUARD GROUP INC4.48%0.00%6,478,304650,50611.16%209,314,002Mar 31, 2024
BLACKROCK INC.3.10%0.00%4,476,800-53,916-1.19%144,645,407Mar 31, 2024
STATE STREET CORP2.52%0.01%3,641,907425,53113.23%117,670,015Mar 31, 2024
PERCEPTIVE ADVISORS LLC2.05%1.66%2,963,212635,13027.28%95,741,380Mar 31, 2024
ARMISTICE CAPITAL, LLC1.50%0.93%2,164,000728,00050.70%69,918,840Mar 31, 2024
ALPINE GLOBAL MANAGEMENT, LLC1.30%15.29%1,882,704484,33234.64%60,830,166Mar 31, 2024
PRICE T ROWE ASSOCIATES INC /MD/1.29%0.01%1,862,043259,48116.19%60,163,000Mar 31, 2024
VIKING GLOBAL INVESTORS LP1.25%0.22%1,809,1721,809,172100.00%58,454,347Mar 31, 2024
LOGOS GLOBAL MANAGEMENT LP1.23%4.64%1,775,000575,00047.92%57,350,250Mar 31, 2024
POINT72 ASSET MANAGEMENT, L.P.0.96%0.11%1,383,810-1,283,073-48.11%44,710,901Mar 31, 2024
GEODE CAPITAL MANAGEMENT, LLC0.91%0.00%1,316,82743,8613.45%42,552,912Mar 31, 2024
WOODLINE PARTNERS LP0.89%0.38%1,289,504539,23871.87%41,663,874Mar 31, 2024
FRED ALGER MANAGEMENT, LLC0.88%0.20%1,271,762386,89043.72%41,090,630Mar 31, 2024
PICTET ASSET MANAGEMENT HOLDING SA0.88%0.04%1,265,298-42,133-3.22%40,881,778Mar 31, 2024
ROCK SPRINGS CAPITAL MANAGEMENT LP0.80%0.94%1,150,123166,82216.97%37,160,474Mar 31, 2024
NUVEEN ASSET MANAGEMENT, LLC0.76%0.01%1,104,278-122,988-10.02%35,680,367Mar 31, 2024
CAPITAL RESEARCH GLOBAL INVESTORS0.68%0.01%976,237--31,542,217Mar 31, 2024
REDMILE GROUP, LLC0.67%1.15%969,621-7,451-0.76%31,328,455Mar 31, 2024
MORGAN STANLEY0.65%0.00%937,961406,45876.47%30,305,521Mar 31, 2024

Immunovant's largest institutional shareholder is FMR LLC, holding 5.30% of the company's total share outstanding, currently valued at $247.36M. The top 10 institutional shareholders own together 24.02% of the company.

Institutional Shareholders by % of Total Assets

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
ALPINE GLOBAL MANAGEMENT, LLC1.30%15.29%1,882,704484,33234.64%60,830,166Mar 31, 2024
STEMPOINT CAPITAL LP0.43%5.36%627,228305,21394.78%20,265,737Mar 31, 2024
LOGOS GLOBAL MANAGEMENT LP1.23%4.64%1,775,000575,00047.92%57,350,250Mar 31, 2024
TWO SEAS CAPITAL LP0.37%3.43%541,295342,543172.35%17,489,241Mar 31, 2024
FIRST TURN MANAGEMENT, LLC0.35%2.48%512,893--16,571,573Mar 31, 2024
ACUTA CAPITAL PARTNERS, LLC0.06%1.94%92,346-27,143-22.72%2,983,699Mar 31, 2024
TYRO CAPITAL MANAGEMENT LLC0.07%1.82%97,66752,667117.04%3,155,621Mar 31, 2024
PROSIGHT MANAGEMENT, LP0.13%1.75%195,000195,000100.00%6,300,450Mar 31, 2024
PERCEPTIVE ADVISORS LLC2.05%1.66%2,963,212635,13027.28%95,741,380Mar 31, 2024
COMMODORE CAPITAL LP0.52%1.62%750,990-249,010-24.90%24,264,487Mar 31, 2024
GHOST TREE CAPITAL, LLC0.10%1.34%150,000150,000100.00%4,846,500Mar 31, 2024
BOXER CAPITAL, LLC0.57%1.32%825,000-175,000-17.50%26,655,750Mar 31, 2024
REDMILE GROUP, LLC0.67%1.15%969,621-7,451-0.76%31,328,455Mar 31, 2024
AFFINITY ASSET ADVISORS, LLC0.20%1.14%285,000-60,000-17.39%9,208,350Mar 31, 2024
GHOST TREE CAPITAL, LLC0.09%1.12%125,000125,000100.00%4,038,750Mar 31, 2024
OCTAGON CAPITAL ADVISORS LP0.19%1.06%273,289--8,829,968Mar 31, 2024
IKARIAN CAPITAL, LLC0.19%0.98%276,92543,53118.65%8,947,446Mar 31, 2024
KNOTT DAVID M JR0.06%0.97%85,30083,8155644.11%2,756,000Mar 31, 2024
ROCK SPRINGS CAPITAL MANAGEMENT LP0.80%0.94%1,150,123166,82216.97%37,160,474Mar 31, 2024
ARMISTICE CAPITAL, LLC1.50%0.93%2,164,000728,00050.70%69,918,840Mar 31, 2024

The largest Immunovant shareholder by % of total assets is ALPINE GLOBAL MANAGEMENT, LLC. The company owns 1.88M shares of Immunovant (IMVT), representing 15.29% of its total assets.

Institutional Buyers

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
VIKING GLOBAL INVESTORS LP1.25%0.22%1,809,1721,809,172100.00%58,454,347Mar 31, 2024
PARADIGM BIOCAPITAL ADVISORS LP0.55%0.91%799,054799,054100.00%25,817,435Mar 31, 2024
ARMISTICE CAPITAL, LLC1.50%0.93%2,164,000728,00050.70%69,918,840Mar 31, 2024
VANGUARD GROUP INC4.48%0.00%6,478,304650,50611.16%209,314,002Mar 31, 2024
PERCEPTIVE ADVISORS LLC2.05%1.66%2,963,212635,13027.28%95,741,380Mar 31, 2024
LOGOS GLOBAL MANAGEMENT LP1.23%4.64%1,775,000575,00047.92%57,350,250Mar 31, 2024
WOODLINE PARTNERS LP0.89%0.38%1,289,504539,23871.87%41,663,874Mar 31, 2024
ALPINE GLOBAL MANAGEMENT, LLC1.30%15.29%1,882,704484,33234.64%60,830,166Mar 31, 2024
STATE STREET CORP2.52%0.01%3,641,907425,53113.23%117,670,015Mar 31, 2024
MORGAN STANLEY0.65%0.00%937,961406,45876.47%30,305,521Mar 31, 2024
FRED ALGER MANAGEMENT, LLC0.88%0.20%1,271,762386,89043.72%41,090,630Mar 31, 2024
TWO SEAS CAPITAL LP0.37%3.43%541,295342,543172.35%17,489,241Mar 31, 2024
FRANKLIN RESOURCES INC0.60%0.01%869,216330,11961.24%28,084,369Mar 31, 2024
RENAISSANCE TECHNOLOGIES LLC0.23%0.02%339,700321,4001756.28%10,976,000Mar 31, 2024
STEMPOINT CAPITAL LP0.43%5.36%627,228305,21394.78%20,265,737Mar 31, 2024
AVIDITY PARTNERS MANAGEMENT LP0.35%0.53%505,000260,000106.12%16,316,550Mar 31, 2024
PRICE T ROWE ASSOCIATES INC /MD/1.29%0.01%1,862,043259,48116.19%60,163,000Mar 31, 2024
SUSQUEHANNA INTERNATIONAL GROUP, LLP0.18%0.00%253,000253,000100.00%8,174,430Mar 31, 2024
STEMPOINT CAPITAL LP0.17%0.08%250,000250,000100.00%318,750Mar 31, 2024
SUSQUEHANNA INTERNATIONAL GROUP, LLP0.17%0.00%243,643243,643100.00%7,872,106Mar 31, 2024

As of Mar 31 2024, Immunovant's largest institutional buyer is VIKING GLOBAL INVESTORS LP. The company purchased 1.81M stocks of IMVT, valued at $58.45M.

Institutional Sellers

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
POINT72 ASSET MANAGEMENT, L.P.0.96%0.11%1,383,810-1,283,073-48.11%44,710,901Mar 31, 2024
ADAGE CAPITAL PARTNERS GP, L.L.C.0.07%0.01%100,000-1,231,780-92.49%3,231,000Mar 31, 2024
CORMORANT ASSET MANAGEMENT, LP----1,165,000-100.00%-Mar 31, 2024
CITADEL ADVISORS LLC0.16%0.00%228,499-582,940-71.84%7,382,803Mar 31, 2024
JANE STREET GROUP, LLC0.05%0.00%67,605-546,736-89.00%2,184,318Mar 31, 2024
DEEP TRACK CAPITAL, LP0.34%0.46%493,352-506,648-50.66%15,940,203Mar 31, 2024
SKANDINAVISKA ENSKILDA BANKEN AB (PUBL)0.19%0.04%277,022-404,913-59.38%8,928,696Mar 31, 2024
FARALLON CAPITAL MANAGEMENT LLC----341,000-100.00%-Mar 31, 2024
JENNISON ASSOCIATES LLC----313,205-100.00%-Mar 31, 2024
BVF INC/IL----300,000-100.00%-Mar 31, 2024
COMMODORE CAPITAL LP0.52%1.62%750,990-249,010-24.90%24,264,487Mar 31, 2024
JPMORGAN CHASE & CO0.17%0.00%245,033-225,957-47.97%7,917,016Mar 31, 2024
SOFINNOVA INVESTMENTS, INC.----222,553-100.00%-Mar 31, 2024
FMR LLC5.30%0.02%7,655,945-219,877-2.79%247,363,595Mar 31, 2024
MILLENNIUM MANAGEMENT LLC0.32%0.01%459,027-212,374-31.63%14,831,162Mar 31, 2024
SUPERSTRING CAPITAL MANAGEMENT LP----203,592-100.00%-Mar 31, 2024
BOXER CAPITAL, LLC0.57%1.32%825,000-175,000-17.50%26,655,750Mar 31, 2024
IKARIAN CAPITAL, LLC----164,700-100.00%-Mar 31, 2024
ABRDN PLC0.13%0.01%187,636-140,070-42.74%6,062,519Mar 31, 2024
SOROS FUND MANAGEMENT LLC----140,000-100.00%-Mar 31, 2024

As of Mar 31 2024, Immunovant's biggest institutional seller is POINT72 ASSET MANAGEMENT, L.P.. The company sold -1.28M shares of IMVT, valued at $44.71M.

Institutional New positions

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
VIKING GLOBAL INVESTORS LP1.25%0.22%1,809,1721,809,172100.00%58,454,347Mar 31, 2024
PARADIGM BIOCAPITAL ADVISORS LP0.55%0.91%799,054799,054100.00%25,817,435Mar 31, 2024
SUSQUEHANNA INTERNATIONAL GROUP, LLP0.18%0.00%253,000253,000100.00%8,174,430Mar 31, 2024
STEMPOINT CAPITAL LP0.17%0.08%250,000250,000100.00%318,750Mar 31, 2024
SUSQUEHANNA INTERNATIONAL GROUP, LLP0.17%0.00%243,643243,643100.00%7,872,106Mar 31, 2024
SUSQUEHANNA INTERNATIONAL GROUP, LLP0.15%0.00%218,600218,600100.00%7,062,966Mar 31, 2024
PROSIGHT MANAGEMENT, LP0.13%1.75%195,000195,000100.00%6,300,450Mar 31, 2024
GHOST TREE CAPITAL, LLC0.10%1.34%150,000150,000100.00%4,846,500Mar 31, 2024
AFFINITY ASSET ADVISORS, LLC0.10%0.58%144,400144,400100.00%4,665,564Mar 31, 2024
PERCEPTIVE ADVISORS LLC0.07%0.06%100,000100,000100.00%3,231,000Mar 31, 2024
CASTLEARK MANAGEMENT LLC0.06%0.11%80,44080,440100.00%2,599,016Mar 31, 2024
TWIN TREE MANAGEMENT, LP0.05%0.01%70,10070,100100.00%2,264,931Mar 31, 2024
AQUATIC CAPITAL MANAGEMENT LLC0.04%0.05%52,00052,000100.00%1,680,120Mar 31, 2024
NOMURA HOLDINGS INC0.03%0.00%50,00050,000100.00%1,615,500Mar 31, 2024
PEARL RIVER CAPITAL, LLC0.02%0.13%26,05326,053100.00%841,772Mar 31, 2024
NOMURA HOLDINGS INC0.02%0.00%25,70825,708100.00%830,625Mar 31, 2024
CLEAR STREET MARKETS LLC0.01%0.11%20,00020,000100.00%646,000Mar 31, 2024
DYNAMIC TECHNOLOGY LAB PRIVATE LTD0.01%0.06%17,67017,670100.00%571,000Mar 31, 2024
CANTOR FITZGERALD, L. P.0.01%0.13%17,33517,335100.00%560,094Mar 31, 2024
VERITION FUND MANAGEMENT LLC0.01%0.00%9,3609,360100.00%302,422Mar 31, 2024
DNB ASSET MANAGEMENT AS0.01%0.00%9,3329,332100.00%301,517Mar 31, 2024
XTX TOPCO LTD0.01%0.04%9,2379,237100.00%298,447Mar 31, 2024
TWINBEECH CAPITAL LP0.01%0.00%7,4017,401100.00%239,126Mar 31, 2024
HSBC HOLDINGS PLC0.01%0.00%7,2987,298100.00%235,798Mar 31, 2024
PEAK6 INVESTMENTS LLC0.00%0.00%6,5006,500100.00%210,015Mar 31, 2024
TWIN TREE MANAGEMENT, LP0.00%0.00%2,2002,200100.00%71,082Mar 31, 2024
PACER ADVISORS, INC.0.00%0.00%1,3431,343100.00%43,392Mar 31, 2024
OLD POINT TRUST & FINANCIAL SERVICES N A0.00%0.00%250250100.00%8,078Mar 31, 2024
CI INVESTMENTS INC.0.00%-110110100.00%4,000Mar 31, 2024
CWM, LLC--5353100.00%2,000Mar 31, 2024
NELSON, VAN DENBURG & CAMPBELL WEALTH MANAGEMENT GROUP, LLC--1111100.00%355Mar 31, 2024

Immunovant's largest new institutional shareholder by number of shares is VIKING GLOBAL INVESTORS LP, purchased 1.81M shares, valued at $58.45M, as of undefined.

Institutional Sold Out

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
CORMORANT ASSET MANAGEMENT, LP----1,165,000-100.00%-Mar 31, 2024
FARALLON CAPITAL MANAGEMENT LLC----341,000-100.00%-Mar 31, 2024
JENNISON ASSOCIATES LLC----313,205-100.00%-Mar 31, 2024
BVF INC/IL----300,000-100.00%-Mar 31, 2024
SOFINNOVA INVESTMENTS, INC.----222,553-100.00%-Mar 31, 2024
SUPERSTRING CAPITAL MANAGEMENT LP----203,592-100.00%-Mar 31, 2024
IKARIAN CAPITAL, LLC----164,700-100.00%-Mar 31, 2024
SOROS FUND MANAGEMENT LLC----140,000-100.00%-Mar 31, 2024
HIGHVISTA STRATEGIES LLC----121,287-100.00%-Mar 31, 2024
HRT FINANCIAL LP----92,731-100.00%-Mar 31, 2024
TWO SEAS CAPITAL LP----86,600-100.00%-Mar 31, 2024
LIGHTHOUSE INVESTMENT PARTNERS, LLC----86,180-100.00%-Mar 31, 2024
ALTIUM CAPITAL MANAGEMENT LP----80,000-100.00%-Mar 31, 2024
BOOTHBAY FUND MANAGEMENT, LLC----71,500-100.00%-Mar 31, 2024
COWEN AND COMPANY, LLC----69,410-100.00%-Mar 31, 2024
ALYESKA INVESTMENT GROUP, L.P.----61,820-100.00%-Mar 31, 2024
NEUBERGER BERMAN GROUP LLC----43,720-100.00%-Mar 31, 2024
HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND----33,000-100.00%-Mar 31, 2024
GTS SECURITIES LLC----27,600-100.00%-Mar 31, 2024
VELAN CAPITAL INVESTMENT MANAGEMENT LP----27,500-100.00%-Mar 31, 2024
TORNO CAPITAL, LLC----25,000-100.00%-Mar 31, 2024
NEW YORK LIFE INVESTMENT MANAGEMENT LLC----22,438-100.00%-Mar 31, 2024
JEFFERIES FINANCIAL GROUP INC.----21,574-100.00%-Mar 31, 2024
WALLEYE TRADING LLC----20,390-100.00%-Mar 31, 2024
SILVERARC CAPITAL MANAGEMENT, LLC----20,000-100.00%-Mar 31, 2024
TWO SIGMA ADVISERS, LP----19,400-100.00%-Mar 31, 2024
NATIXIS----16,900-100.00%-Mar 31, 2024
BARCLAYS PLC----15,000-100.00%-Mar 31, 2024
FOX RUN MANAGEMENT, L.L.C.----14,534-100.00%-Mar 31, 2024
JUPITER ASSET MANAGEMENT LTD----11,165-100.00%-Mar 31, 2024
CAPTRUST FINANCIAL ADVISORS----10,792-100.00%-Mar 31, 2024
MAVEN SECURITIES LTD----10,000-100.00%-Mar 31, 2024
BALYASNY ASSET MANAGEMENT L.P.----9,783-100.00%-Mar 31, 2024
Y-INTERCEPT (HONG KONG) LTD----9,241-100.00%-Mar 31, 2024
GSA CAPITAL PARTNERS LLP----8,760-100.00%-Mar 31, 2024
ENGINEERS GATE MANAGER LP----8,451-100.00%-Mar 31, 2024
JFG WEALTH MANAGEMENT, LLC----7,000-100.00%-Mar 31, 2024
BAILARD, INC.----6,300-100.00%-Mar 31, 2024
PICTET & CIE (EUROPE) SA----5,512-100.00%-Mar 31, 2024
ATOM INVESTORS LP----5,431-100.00%-Mar 31, 2024
FEDERATED HERMES, INC.----2,979-100.00%-Mar 31, 2024
BELVEDERE TRADING LLC----1,800-100.00%-Mar 31, 2024
POINT72 ASIA (SINGAPORE) PTE. LTD.----1,104-100.00%-Mar 31, 2024
HEADLANDS TECHNOLOGIES LLC----636-100.00%-Mar 31, 2024
ITAU UNIBANCO HOLDING S.A.----65-100.00%-Mar 31, 2024
FORTITUDE FAMILY OFFICE, LLC----21-100.00%-Mar 31, 2024
BELL INVESTMENT ADVISORS, INC----15-100.00%-Mar 31, 2024
TFO-TDC, LLC----9-100.00%-Mar 31, 2024
GRADIENT INVESTMENTS LLC----2-100.00%-Mar 31, 2024

Immunovant's largest sold out institutional shareholder by shares sold is CORMORANT ASSET MANAGEMENT, LP, sold -1.17M shares, valued at -, as of undefined.

Immunovant Mutual Fund Holders


Name% Total AssetsTotal SharesChange AmountChange %Date
Eaton Vance Enhanced Equity Income Fund II1.15%102,760--Dec 31, 2023
ALGER FUNDS II0.84%190,114190,114-Jan 31, 2024
ALGER FUNDS0.81%779,496-197,159-20.19%Jan 31, 2024
Tax-Managed Multi-Cap Growth Portfolio0.74%19,759--Jan 31, 2024
ALGER INSTITUTIONAL FUNDS0.57%149,560110,940287.26%Jan 31, 2024
LORD ABBETT DEVELOPING GROWTH FUND, INC.0.52%486,055175,11556.32%Jan 31, 2024
TEKLA HEALTHCARE INVESTORS0.19%219,148-95,127-30.27%Dec 31, 2023
TEKLA LIFE SCIENCES INVESTORS0.19%108,558-41,842-27.82%Dec 31, 2023
FIDELITY MT VERNON STREET TRUST0.13%3,770,260-164,250-4.17%Feb 29, 2024
ALGER PORTFOLIOS0.13%47,894--Dec 31, 2023
PRUDENTIAL SECTOR FUNDS, INC.0.10%204,666--Feb 29, 2024
BlackRock Health Sciences Trust II0.09%256,486--Dec 31, 2023
VANGUARD VALLEY FORGE FUNDS0.09%44,500--Dec 31, 2023
Tema ETF Trust0.08%3,4323,432-Feb 29, 2024
BlackRock Health Sciences Trust0.07%30,416--Dec 31, 2023
Humankind Benefit Corp0.06%1,363--Dec 31, 2023
T. Rowe Price Quantitative Management Funds, Inc.0.06%201,318111,400123.89%Dec 31, 2023
T. Rowe Price New Horizons Fund, Inc.0.04%629,335453,014256.93%Dec 31, 2023
AMG FUNDS III0.04%6,890--Feb 29, 2024
EATON VANCE GROWTH TRUST0.04%103,205--Feb 29, 2024
EATON VANCE SPECIAL INVESTMENT TRUST0.04%38,669--Jan 31, 2024
VIRTUS ALTERNATIVE SOLUTIONS TRUST0.03%135--Jan 31, 2024
ALLSPRING VARIABLE TRUST0.02%13,50013,500-Dec 31, 2023
VICTORY VARIABLE INSURANCE FUNDS0.02%12,040-1,310-9.81%Dec 31, 2023
DEUTSCHE DWS INVESTMENTS VIT FUNDS0.02%8,197--Dec 31, 2023
Vericimetry Funds0.02%1,790--Dec 31, 2023
DRIEHAUS MUTUAL FUNDS0.02%127,953--Dec 29, 2023
QUANTITATIVE MASTER SERIES LLC0.01%98,2456,7507.38%Dec 31, 2023
VANGUARD INDEX FUNDS0.01%6,019,730530,2219.66%Dec 31, 2023
Federated Hermes MDT Series0.01%32,011--Jan 31, 2024
FIDELITY SELECT PORTFOLIOS0.01%822,543-59,300-6.72%Feb 29, 2024
FIDELITY COMMONWEALTH TRUST0.01%38,3334,01411.70%Feb 29, 2024
SMALLCAP WORLD FUND INC0.01%780,367189,86732.15%Dec 31, 2023
IndexIQ ETF Trust0.01%20,982-1,428-6.37%Jan 31, 2024
ALPS ETF Trust0.01%92,302--Feb 29, 2024
BARON SELECT FUNDS0.00%59,00059,000-Dec 31, 2023
RYDEX SERIES FUNDS0.00%20,85520,3634138.82%Dec 31, 2023
TIAA SEPARATE ACCOUNT VA 10.00%1,107--Dec 31, 2023
AIM GROWTH SERIES (INVESCO GROWTH SERIES)0.00%165,98757,95453.64%Dec 31, 2023
VICTORY PORTFOLIOS0.00%122,840-19,030-13.41%Dec 31, 2023
UBS FUNDS0.00%18,64618,646-Dec 31, 2023
FIRST TRUST EXCHANGE-TRADED FUND0.00%37,48837,488-Dec 31, 2023
INVESCO EXCHANGE-TRADED FUND TRUST0.00%232,210--Jan 31, 2024
FIDELITY CONCORD STREET TRUST0.00%580,92419,7843.53%Feb 29, 2024
ProFunds0.00%25,14211,84789.11%Jan 31, 2024
Calvert Variable Products, Inc.0.00%5,5852244.18%Dec 31, 2023
NEUBERGER BERMAN EQUITY FUNDS0.00%22,249--Feb 29, 2024
RYDEX VARIABLE TRUST0.00%2,2462,2146918.75%Dec 31, 2023
VANGUARD EXPLORER FUND0.00%19,614--Jan 31, 2024
SCHWAB STRATEGIC TRUST0.00%296,36715,1035.37%Feb 29, 2024
Direxion Shares ETF Trust0.00%219,949-13,114-5.63%Jan 31, 2024
ETFis Series Trust I0.00%1,927-2,720-58.53%Jan 31, 2024
VANGUARD INSTITUTIONAL INDEX FUNDS0.00%39,614-3,112-7.28%Dec 31, 2023
Principal Exchange-Traded Funds0.00%15,532-1,276-7.59%Mar 31, 2024
TIAA-CREF LIFE FUNDS0.00%3,381-4,606-57.67%Dec 31, 2023
MASSMUTUAL PREMIER FUNDS0.00%34,58011,21447.99%Dec 31, 2023
Fidelity Commonwealth Trust II0.00%8,130-30,163-78.77%Aug 31, 2023
FINANCIAL INVESTORS TRUST0.00%91,651-213,571-69.97%Jan 31, 2024
FEDERATED HERMES INSURANCE SERIES0.00%4,257--Dec 31, 2023
T. Rowe Price Index Trust, Inc.0.00%16,340--Feb 29, 2024
COLLEGE RETIREMENT EQUITIES FUND0.00%855,039355,77971.26%Dec 31, 2023
VANGUARD WORLD FUND0.00%172,011-27,539-13.80%Feb 29, 2024
Voya VARIABLE PORTFOLIOS INC0.00%21,572-66-0.31%Dec 31, 2023
BlackRock ETF Trust0.00%600--Jan 31, 2024
VARIABLE INSURANCE PRODUCTS FUND II0.00%8,207-502-5.76%Dec 31, 2023
STATE STREET VARIABLE INSURANCE SERIES FUNDS INC0.00%2,667-157-5.56%Dec 31, 2023
LORD ABBETT SERIES FUND INC0.00%13,42013,420-Dec 31, 2023
SunAmerica Specialty Series0.00%288--Apr 30, 2021
Dimensional ETF Trust0.00%228,005--Jan 31, 2024
VANGUARD HORIZON FUNDS0.00%10,279--Dec 31, 2023
FIDELITY COVINGTON TRUST0.00%6,629-1-0.02%Feb 29, 2024
VANGUARD VARIABLE INSURANCE FUNDS0.00%24,314--Dec 31, 2023
GOLDMAN SACHS VARIABLE INSURANCE TRUST0.00%1,666--Dec 31, 2023
THRIVENT SERIES FUND INC0.00%46,491--Dec 29, 2023
VANGUARD QUANTITATIVE FUNDS0.00%3,600--Dec 31, 2023
AMERICAN CENTURY STRATEGIC ASSET ALLOCATIONS INC0.00%5,452--Jan 31, 2024
PRINCIPAL VARIABLE CONTRACTS FUNDS INC0.00%15,079--Dec 31, 2023
RUSSELL INVESTMENT CO0.00%109,44767,332159.88%Jan 31, 2024
LORD ABBETT SECURITIES TRUST0.00%1,5971,597-Jan 31, 2024
RBB FUND, INC.0.00%32,076--Feb 29, 2024
ALLSPRING MASTER TRUST0.00%20,94115,989322.88%Feb 29, 2024
FundVantage Trust0.00%1,468--Jan 31, 2024
Voya INVESTORS TRUST0.00%15,363-17,695-53.53%Dec 31, 2023
DFA INVESTMENT DIMENSIONS GROUP INC0.00%286,47556,93324.80%Jan 31, 2024
OPTIMUM FUND TRUST0.00%41,023-9,328-18.53%Dec 29, 2023
PUTNAM VARIABLE TRUST0.00%6,105--Dec 31, 2023
SEASONS SERIES TRUST0.00%6,222-4,323-41.00%Dec 31, 2023
ADVISORS' INNER CIRCLE FUND0.00%3,296--Jan 31, 2024
SSGA FUNDS0.00%106--Feb 29, 2024
PUTNAM ASSET ALLOCATION FUNDS0.00%493-25,288-98.09%Feb 29, 2024
STATE STREET INSTITUTIONAL INVESTMENT TRUST0.00%19,4001,3007.18%Dec 31, 2023
GPS Funds I0.00%1,006--Dec 31, 2023
MUTUAL FUND SERIES TRUST0.00%651,900--Dec 31, 2023
RUSSELL INVESTMENT FUNDS0.00%10,9506,537148.13%Dec 31, 2023
THRIVENT MUTUAL FUNDS0.00%13,694--Jan 31, 2024
Nushares ETF Trust0.00%1,15530936.52%Jan 31, 2024
Federated Hermes Global Allocation Fund0.00%1,525--Feb 29, 2024
EQ ADVISORS TRUST0.00%163,4257,1364.57%Dec 31, 2023
Victory Portfolios II0.00%7,949-13,726-63.33%Dec 31, 2023
OHIO NATIONAL FUND INC0.00%2,5952,595-Dec 31, 2023

Immunovant's largest mutual fund holder by % of total assets is "Eaton Vance Enhanced Equity Income Fund II", owning 102.76K shares, compromising 1.15% of its total assets.

Immunovant Institutional Ownership Trends


Institutional Holdings Trend

DateHoldingsChange %
31 Mar, 24232-7.20%
31 Dec, 2325018.48%
30 Sep, 2321137.01%
30 Jun, 231544.05%
31 Mar, 231488.82%
31 Dec, 2213621.43%
30 Sep, 2211220.43%
30 Jun, 2293-19.83%
31 Mar, 22116-6.45%
31 Dec, 21124-4.62%
30 Sep, 21130-
30 Jun, 21130-
31 Mar, 21130-10.96%
31 Dec, 2014626.96%
30 Sep, 2011532.18%
30 Jun, 2087112.20%
31 Mar, 204170.83%
31 Dec, 1924-

As of 31 Mar 24, 232 institutions are holding Immunovant's shares, representing a decrease of -7.20% compared to the previous quarter.

Shares Outstanding Trend

DateShares OutstandingChange %
31 Mar, 2469,680,1492.23%
31 Dec, 2368,161,4602.04%
30 Sep, 2366,800,56420.49%
30 Jun, 2355,442,928-4.61%
31 Mar, 2358,122,1562.87%
31 Dec, 2256,500,69332.49%
30 Sep, 2242,646,8566.32%
30 Jun, 2240,111,3121.63%
31 Mar, 2239,468,7954.74%
31 Dec, 2137,681,72312.41%
30 Sep, 2133,522,026-12.49%
30 Jun, 2138,306,307-5.21%
31 Mar, 2140,413,3370.23%
31 Dec, 2040,320,8802.38%
30 Sep, 2039,382,63037.87%
30 Jun, 2028,564,753126.19%
31 Mar, 2012,628,6768.50%
31 Dec, 1911,639,232-

Immunovant (IMVT) has 69.68M shares outstanding as of 31 Mar 24, up 2.23% compared to the previous quarter.

Institutional Ownership Trend

DateOwnership %Change %
31 Mar, 2448.21%2.17%
31 Dec, 2347.16%1.80%
30 Sep, 2351.19%2.52%
30 Jun, 2345.05%2.24%
31 Mar, 2344.84%2.32%
31 Dec, 2243.94%3.28%
30 Sep, 2236.58%3.09%
30 Jun, 2234.41%2.66%
31 Mar, 2235.99%3.35%
31 Dec, 2132.76%3.47%
30 Sep, 2130.73%2.01%
30 Jun, 2139.10%1.84%
31 Mar, 2146.05%2.72%
31 Dec, 2041.18%1.89%
30 Sep, 2046.69%2.87%
30 Jun, 2040.33%4.72%
31 Mar, 2029.23%3.63%
31 Dec, 1928.36%-

As of 31 Mar 24, Immunovant is held by 48.21% institutional shareholders, representing a 2.17% growth compared to 31 Dec 23.

Institutional Increased Positions Trend

DateIncreased PositionsChange %
31 Mar, 24106-21.48%
31 Dec, 231352.27%
30 Sep, 2313250.00%
30 Jun, 23887.32%
31 Mar, 2382-8.89%
31 Dec, 229052.54%
30 Sep, 225937.21%
30 Jun, 2243-17.31%
31 Mar, 2252-13.33%
31 Dec, 2160-14.29%
30 Sep, 21704.48%
30 Jun, 2167-17.28%
31 Mar, 2181-17.35%
31 Dec, 20987.69%
30 Sep, 209119.74%
30 Jun, 2076153.33%
31 Mar, 203025.00%
31 Dec, 1924-

106 institutional shareholders have increased their position in IMVT stock as of 31 Mar 24 compared to 135 in the previous quarter (a -21.48% decrease).

Institutional Reduced Positions Trend

DateReduced PositionsChange %
31 Mar, 24813.85%
31 Dec, 237869.57%
30 Sep, 23464.55%
30 Jun, 23447.32%
31 Mar, 234136.67%
31 Dec, 2230-9.09%
30 Sep, 223317.86%
30 Jun, 2228-36.36%
31 Mar, 2244-4.35%
31 Dec, 214627.78%
30 Sep, 2136-
30 Jun, 213616.13%
31 Mar, 2131-18.42%
31 Dec, 203890.00%
30 Sep, 202081.82%
30 Jun, 201157.14%
31 Mar, 207-
31 Dec, 19--

81 institutional shareholders have reduced their position in IMVT stock as of 31 Mar 24 compared to 78 in the previous quarter (a 3.85% increase).

All Institutional Ownership Trend Data

DateHoldingsChange %Shares OutstandingChange %Ownership %Change %Increased PositionsChange %Reduced PositionsChange %
31 Mar, 24232-7.20%69,680,1492.23%48.21%2.17%106-21.48%813.85%
31 Dec, 2325018.48%68,161,4602.04%47.16%1.80%1352.27%7869.57%
30 Sep, 2321137.01%66,800,56420.49%51.19%2.52%13250.00%464.55%
30 Jun, 231544.05%55,442,928-4.61%45.05%2.24%887.32%447.32%
31 Mar, 231488.82%58,122,1562.87%44.84%2.32%82-8.89%4136.67%
31 Dec, 2213621.43%56,500,69332.49%43.94%3.28%9052.54%30-9.09%
30 Sep, 2211220.43%42,646,8566.32%36.58%3.09%5937.21%3317.86%
30 Jun, 2293-19.83%40,111,3121.63%34.41%2.66%43-17.31%28-36.36%
31 Mar, 22116-6.45%39,468,7954.74%35.99%3.35%52-13.33%44-4.35%
31 Dec, 21124-4.62%37,681,72312.41%32.76%3.47%60-14.29%4627.78%
30 Sep, 21130-33,522,026-12.49%30.73%2.01%704.48%36-
30 Jun, 21130-38,306,307-5.21%39.10%1.84%67-17.28%3616.13%
31 Mar, 21130-10.96%40,413,3370.23%46.05%2.72%81-17.35%31-18.42%
31 Dec, 2014626.96%40,320,8802.38%41.18%1.89%987.69%3890.00%
30 Sep, 2011532.18%39,382,63037.87%46.69%2.87%9119.74%2081.82%
30 Jun, 2087112.20%28,564,753126.19%40.33%4.72%76153.33%1157.14%
31 Mar, 204170.83%12,628,6768.50%29.23%3.63%3025.00%7-
31 Dec, 1924-11,639,232-28.36%-24---

Immunovant Insider Shareholders Trades


Open Market Insider Trades

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource
Apr 26, 2024Geffner Michaelofficer Chief Medical OfficerS-SaleSell3,261$28.90$94.24K141,616
Apr 26, 2024Stout Jay Sofficer Chief Technology OfficerS-SaleSell7,239$28.90$209.21K147,739
Apr 26, 2024Levine Mark S.officer Chief Legal OfficerS-SaleSell3,963$28.90$114.53K343,156
Apr 19, 2024Levine Mark S.officer Chief Legal OfficerS-SaleSell7,602$28.80$218.94K349,344
Apr 19, 2024Levine Mark S.officer Chief Legal OfficerS-SaleSell2,225$29.94$66.62K347,119
Apr 19, 2024Macias William L.officer Chief Medical OfficerS-SaleSell6,136$28.80$176.72K379,794
Apr 19, 2024Macias William L.officer Chief Medical OfficerS-SaleSell1,796$29.94$53.77K377,998
Apr 19, 2024Macias William L.officer Chief Medical OfficerS-SaleSell269$28.80$7.75K377,729
Apr 19, 2024Macias William L.officer Chief Medical OfficerS-SaleSell79$29.94$2.37K377,650
Apr 19, 2024Barnett Eva Reneeofficer Chief Financial OfficerS-SaleSell9,479$28.80$273.00K362,230
Apr 19, 2024Barnett Eva Reneeofficer Chief Financial OfficerS-SaleSell2,774$29.94$83.05K359,456
Apr 19, 2024Butchko Julia G.officer Chief Development OfficerS-SaleSell7,825$28.80$225.36K453,917
Apr 19, 2024Butchko Julia G.officer Chief Development OfficerS-SaleSell2,290$29.94$68.56K451,627
Apr 19, 2024Salzmann Peterdirector, officer Chief Executive OfficerS-SaleSell26,365$28.80$759.31K1,060,593
Apr 19, 2024Salzmann Peterdirector, officer Chief Executive OfficerS-SaleSell7,714$29.94$230.96K1,052,879
Apr 10, 2024Barnett Eva Reneeofficer Chief Financial OfficerS-SaleSell3,689$31.18$115.02K371,709
Apr 10, 2024Butchko Julia G.officer Chief Development OfficerS-SaleSell1,053$31.18$32.83K461,742
Apr 10, 2024Salzmann Peterdirector, officer Chief Executive OfficerS-SaleSell4,807$31.18$149.88K1,086,958

Open Market Insider Buys

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource

Insider Sells

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource
Apr 26, 2024Geffner Michaelofficer Chief Medical OfficerS-SaleSell3,261$28.90$94.24K141,616
Apr 26, 2024Stout Jay Sofficer Chief Technology OfficerS-SaleSell7,239$28.90$209.21K147,739
Apr 26, 2024Levine Mark S.officer Chief Legal OfficerS-SaleSell3,963$28.90$114.53K343,156
Apr 19, 2024Levine Mark S.officer Chief Legal OfficerS-SaleSell7,602$28.80$218.94K349,344
Apr 19, 2024Levine Mark S.officer Chief Legal OfficerS-SaleSell2,225$29.94$66.62K347,119
Apr 19, 2024Macias William L.officer Chief Medical OfficerS-SaleSell6,136$28.80$176.72K379,794
Apr 19, 2024Macias William L.officer Chief Medical OfficerS-SaleSell1,796$29.94$53.77K377,998
Apr 19, 2024Macias William L.officer Chief Medical OfficerS-SaleSell269$28.80$7.75K377,729
Apr 19, 2024Macias William L.officer Chief Medical OfficerS-SaleSell79$29.94$2.37K377,650
Apr 19, 2024Barnett Eva Reneeofficer Chief Financial OfficerS-SaleSell9,479$28.80$273.00K362,230
Apr 19, 2024Barnett Eva Reneeofficer Chief Financial OfficerS-SaleSell2,774$29.94$83.05K359,456
Apr 19, 2024Butchko Julia G.officer Chief Development OfficerS-SaleSell7,825$28.80$225.36K453,917
Apr 19, 2024Butchko Julia G.officer Chief Development OfficerS-SaleSell2,290$29.94$68.56K451,627
Apr 19, 2024Salzmann Peterdirector, officer Chief Executive OfficerS-SaleSell26,365$28.80$759.31K1,060,593
Apr 19, 2024Salzmann Peterdirector, officer Chief Executive OfficerS-SaleSell7,714$29.94$230.96K1,052,879
Apr 10, 2024Barnett Eva Reneeofficer Chief Financial OfficerS-SaleSell3,689$31.18$115.02K371,709
Apr 10, 2024Butchko Julia G.officer Chief Development OfficerS-SaleSell1,053$31.18$32.83K461,742
Apr 10, 2024Salzmann Peterdirector, officer Chief Executive OfficerS-SaleSell4,807$31.18$149.88K1,086,958

All Insider Owners Trades

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource
Apr 26, 2024Geffner Michaelofficer Chief Medical OfficerS-SaleSell3,261$28.90$94.24K141,616
Apr 26, 2024Stout Jay Sofficer Chief Technology OfficerS-SaleSell7,239$28.90$209.21K147,739
Apr 26, 2024Levine Mark S.officer Chief Legal OfficerS-SaleSell3,963$28.90$114.53K343,156
Apr 19, 2024Levine Mark S.officer Chief Legal OfficerS-SaleSell7,602$28.80$218.94K349,344
Apr 19, 2024Levine Mark S.officer Chief Legal OfficerS-SaleSell2,225$29.94$66.62K347,119
Apr 19, 2024Macias William L.officer Chief Medical OfficerS-SaleSell6,136$28.80$176.72K379,794
Apr 19, 2024Macias William L.officer Chief Medical OfficerS-SaleSell1,796$29.94$53.77K377,998
Apr 19, 2024Macias William L.officer Chief Medical OfficerS-SaleSell269$28.80$7.75K377,729
Apr 19, 2024Macias William L.officer Chief Medical OfficerS-SaleSell79$29.94$2.37K377,650
Apr 19, 2024Barnett Eva Reneeofficer Chief Financial OfficerS-SaleSell9,479$28.80$273.00K362,230
Apr 19, 2024Barnett Eva Reneeofficer Chief Financial OfficerS-SaleSell2,774$29.94$83.05K359,456
Apr 19, 2024Butchko Julia G.officer Chief Development OfficerS-SaleSell7,825$28.80$225.36K453,917
Apr 19, 2024Butchko Julia G.officer Chief Development OfficerS-SaleSell2,290$29.94$68.56K451,627
Apr 19, 2024Salzmann Peterdirector, officer Chief Executive OfficerS-SaleSell26,365$28.80$759.31K1,060,593
Apr 19, 2024Salzmann Peterdirector, officer Chief Executive OfficerS-SaleSell7,714$29.94$230.96K1,052,879
Apr 10, 2024Barnett Eva Reneeofficer Chief Financial OfficerS-SaleSell3,689$31.18$115.02K371,709
Apr 10, 2024Butchko Julia G.officer Chief Development OfficerS-SaleSell1,053$31.18$32.83K461,742
Apr 10, 2024Salzmann Peterdirector, officer Chief Executive OfficerS-SaleSell4,807$31.18$149.88K1,086,958
Apr 04, 2024Fromkin Andrew J.director-A-AwardBuy11,255--99,913
Apr 04, 2024Fromkin Andrew J.director-A-AwardBuy4,690$30.78$144.36K4,690

The last insider sell of Immunovant's stock was made by Geffner Michael on Apr 26 2024, selling 3,261 shares at $28.90 per share (valued at $94.24K).

Immunovant Insider Ownership Trends


All Insider Trades Trend

DateBuySellBuy/Sell Ratio
Q2 20242418133.33%
Q1 2024-16-
Q4 20232267.69%
Q3 2023-18-
Q2 2023225440.00%
Q1 2023-9-
Q4 20221425.00%
Q3 2022226366.67%
Q2 2022-7-
Q1 2022126200.00%
Q4 20215--
Q3 2021125240.00%
Q2 20213--
Q1 202125--
Q3 20204--
Q2 202016--
Q1 2020---
Q4 20194222100.00%
Q2 201911100.00%

24 total buy trades, and 18 total sell trades (buy/sell ratio of 1.33%) were made by Immunovant's insiders, as of Q2 2024.

Open Market Insider Trades Trend

DateBuySellBuy/Sell Ratio
Q2 2024-18-
Q1 2024-14-
Q4 20231263.85%
Q3 2023-18-
Q2 2023-5-
Q1 2023-9-
Q4 20221425.00%
Q3 20222633.33%
Q2 2022-7-
Q1 2022-6-
Q4 2021---
Q3 20214--
Q2 2021---
Q1 2021---
Q3 20202--
Q2 20201--
Q1 2020---
Q4 201923--
Q2 20191--

As of Q2 2024, Insider owners conducted 0 open market buy trades and 18 open market sell trades of Immunovant's stocks.

Immunovant Peer Ownership


TickerCompany
ARQTArcutis Biotherapeutics, Inc.
PLRXPliant Therapeutics, Inc.
AKROAkero Therapeutics, Inc.
ETNB89bio, Inc.
ABUSArbutus Biopharma Corporation
STOKStoke Therapeutics, Inc.
DAWNDay One Biopharmaceuticals, Inc.
AMLXAmylyx Pharmaceuticals, Inc.
LEGNLegend Biotech Corporation
BPMCBlueprint Medicines Corporation
MDGLMadrigal Pharmaceuticals, Inc.
APLSApellis Pharmaceuticals, Inc.
ACLXArcellx, Inc.
PTGXProtagonist Therapeutics, Inc.
KRTXKaruna Therapeutics, Inc.

IMVT Ownership FAQ


Immunovant is owned by institutional shareholders (48.21%), insiders (55.98%), and public (-4.20%). The largest institutional shareholder of Immunovant is FMR LLC (5.30% of total shares) and the top mutual fund owner is Eaton Vance Enhanced Equity Income Fund II (1.15% of total shares).

Immunovant's major institutional shareholders are FMR LLC, VANGUARD GROUP INC, BLACKROCK INC., STATE STREET CORP, and PERCEPTIVE ADVISORS LLC. The top five shareholders own together 17.45% of the company's share outstanding.

As of Mar 2024, there are 232 institutional shareholders of Immunovant.

FMR LLC owns 7.66M shares of Immunovant, representing 5.30% of the company's total shares outstanding, valued at $247.36M (as of Mar 2024).

As of Mar 2024, VANGUARD GROUP INC holds 6.48M shares of Immunovant (IMVT), compromising 4.48% of the company, valued at $209.31M.

BLACKROCK INC is the third largest holder of Immunovant. The company owns 4.48M of the company's shares outstanding (worth $144.65M).